`BIB_054`

Robert C, Schachter J, Long GV, et al. Pembrolizumab versus Ipilimumab in Advanced Melanoma. NEJM 2015;372(26):2521–2532. PMID 25891173. KEYNOTE-006. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade: A
Tier: 2
Cited by tasks: L, 18
Identifiers: PMID:25891173

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_054/findings.md (research corpus). This page is a short context summary — not individualised medical advice.